The Role of Glutamatergic Function in the Pathophysiology of Treatment-resistant Schizophrenia

NCT06270108 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

288

Enrollment

OTHER

Sponsor class

Conditions

Treatment-resistant Schizophrenia
Treatment-responsive Schizophrenia
Healthy Controls

Interventions

DRUG: Riluzole

Sponsor

King's College London

Collaborators

[object Object]